OrthoPediatrics (KIDS) Misses Q3 EPS by 11c, updates guidance

OrthoPediatrics (NASDAQ: KIDS) reported Q3 EPS of ($0.34), $0.11 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $54.57 million versus the consensus estimate of $53.73 million.

GUIDANCE:

OrthoPediatrics sees FY2024 revenue of $202-204 million, versus the consensus of $201.8 million.

For earnings history and earnings-related data on OrthoPediatrics (KIDS) click here.

You May Also Be Interested In

• Barrick Mining said to delay IPO of American gold business to 2027
• Zscaler and CrowdStrike expand partnership with new integrations
• Sell Recreational Cannabis as "Medicine"- Federal Class Action Alleges a "Concerted Campaign"